companies / electra-therapeutics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-20 json
| total_raised | 134,188,389134.2M | D |
|---|---|---|
| founded | 2018 | |
| hq | South San Francisco, CA | |
| industry | unknown | |
| stage | null |
Electra Therapeutics develops antibody therapies that target Signal Regulatory Proteins to treat immunological diseases and cancer. It serves patients with inflammatory conditions such as sHLH that lack treatment options, led by ELA026. Its SIRP-targeting approach depletes pathological immune cells while sparing healthy ones.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-10-15 | Funding round | 134,188,389134.2M | null | D |
| person | role | src |
|---|---|---|
| Beth Seidenberg, M.D. | director | D |
| Carl Gordon, Ph.D. | director | D |
| Matthew Fust | director | D |
| Nancy Stagliano, Ph.D. | director | D |
| Quehuong (Kathy) Dong, Pharm.D. | director | D |
| Quehuong (Kathy) Dong, Pharm.D. | executive | D |
| Thomas Geninatti, Ph.D. | director | D |
Cloudflare, reCAPTCHA, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, Cloudflare Bot Management, CookieYes 3.4.0, WordPress, WP Engine, Python, PHP, MySQL
| fact | status | src |
|---|---|---|
| Funding round, $134.2M | sourced | D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28latest_round: Funding round, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15, D 2026-09-25 | latest_round | Funding round, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15 | D 2026-09-25 |
| 2026-09-25latest_round: seed, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15, D 2026-09-25 | latest_round | seed, $134.2M, 2025-10-15 → Funding round, $134.2M, 2025-10-15 | D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, |
| provenance_round |
| attributed → sourced |
| D 2026-09-25 |
Records begin 2026-09-24. all_changes